Relmada Therapeutics pivots to NDV-01 for bladder cancer & Sepranolone for Tourette's. Phase 2 results expected April 2025.

Expect Topline Phase 2 data for NDV-01 for high-grade non-muscle invasive bladder cancer (HG-NMIBC), to be presented at AUA 2025 in ...

Eric Baar from Cambridge was one of 108 young people selected nationwide to attend the Tourette Association of America’s (TAA ...

The 19-year-old's positivity and bright approach has won over those at Port, as it did when he was coming through the ranks ...

Tom Cochrane, son of former Power player Stuart, will become the first player with Tourette syndrome to make his AFL debut.

Port Adelaide youngster Tom Cochrane is set to break barriers when he makes his AFL debut against Essendon on Thursday night.

Tom Cochrane will become the first AFL player with Tourette syndrome when he makes his debut for Port Adelaide against ...

Tom Cochrane is named to face Essendon on Thursday, marking the first time a player with Tourette syndrome will make their ...

Port Adelaide forward Tom Cochrane will keep a promise he made to his mum when he was just nine - and follow in his dad's ...

Tom Cochrane will live out his childhood dream of becoming the first AFL player with Tourette’s syndrome, after being ...